These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 12167626)

  • 21. Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression.
    Yamamoto Y; Verma UN; Prajapati S; Kwak YT; Gaynor RB
    Nature; 2003 Jun; 423(6940):655-9. PubMed ID: 12789342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Signal transduction mechanisms involved in S100A4-induced activation of the transcription factor NF-kappaB.
    Grotterød I; Maelandsmo GM; Boye K
    BMC Cancer; 2010 May; 10():241. PubMed ID: 20507646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NIBP, a novel NIK and IKK(beta)-binding protein that enhances NF-(kappa)B activation.
    Hu WH; Pendergast JS; Mo XM; Brambilla R; Bracchi-Ricard V; Li F; Walters WM; Blits B; He L; Schaal SM; Bethea JR
    J Biol Chem; 2005 Aug; 280(32):29233-41. PubMed ID: 15951441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor.
    Takada Y; Fang X; Jamaluddin MS; Boyd DD; Aggarwal BB
    J Biol Chem; 2004 Sep; 279(38):39541-54. PubMed ID: 15252041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TNF-α Modulation of Intestinal Tight Junction Permeability Is Mediated by NIK/IKK-α Axis Activation of the Canonical NF-κB Pathway.
    Al-Sadi R; Guo S; Ye D; Rawat M; Ma TY
    Am J Pathol; 2016 May; 186(5):1151-65. PubMed ID: 26948423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-kappa B activation through inhibition of activation of I kappa B alpha kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synthesis.
    Shishodia S; Koul D; Aggarwal BB
    J Immunol; 2004 Aug; 173(3):2011-22. PubMed ID: 15265936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arsenic inhibits NF-kappaB-mediated gene transcription by blocking IkappaB kinase activity and IkappaBalpha phosphorylation and degradation.
    Roussel RR; Barchowsky A
    Arch Biochem Biophys; 2000 May; 377(1):204-12. PubMed ID: 10775461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteopontin induces nuclear factor kappa B-mediated promatrix metalloproteinase-2 activation through I kappa B alpha /IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways.
    Philip S; Kundu GC
    J Biol Chem; 2003 Apr; 278(16):14487-97. PubMed ID: 12473670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The signal transduction pathway of CD23 (Fc epsilon RIIb) targets I kappa B kinase.
    Ten RM; McKinstry MJ; Trushin SA; Asin S; Paya CV
    J Immunol; 1999 Oct; 163(7):3851-7. PubMed ID: 10490984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IKK beta plays an essential role in the phosphorylation of RelA/p65 on serine 536 induced by lipopolysaccharide.
    Yang F; Tang E; Guan K; Wang CY
    J Immunol; 2003 Jun; 170(11):5630-5. PubMed ID: 12759443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydrogen peroxide-mediated inhibition of lipopolysaccharide-stimulated inhibitory kappa B kinase activity in rat aortic smooth muscle cells.
    Torrie LJ; MacKenzie CJ; Paul A; Plevin R
    Br J Pharmacol; 2001 Sep; 134(2):393-401. PubMed ID: 11564658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A nucleosomal function for IkappaB kinase-alpha in NF-kappaB-dependent gene expression.
    Anest V; Hanson JL; Cogswell PC; Steinbrecher KA; Strahl BD; Baldwin AS
    Nature; 2003 Jun; 423(6940):659-63. PubMed ID: 12789343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IKKalpha, IKKbeta, and NEMO/IKKgamma are each required for the NF-kappa B-mediated inflammatory response program.
    Li X; Massa PE; Hanidu A; Peet GW; Aro P; Savitt A; Mische S; Li J; Marcu KB
    J Biol Chem; 2002 Nov; 277(47):45129-40. PubMed ID: 12221085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell type-specific expression of the IkappaB kinases determines the significance of phosphatidylinositol 3-kinase/Akt signaling to NF-kappa B activation.
    Gustin JA; Ozes ON; Akca H; Pincheira R; Mayo LD; Li Q; Guzman JR; Korgaonkar CK; Donner DB
    J Biol Chem; 2004 Jan; 279(3):1615-20. PubMed ID: 14585846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p38 MAPK and NF-kappa B collaborate to induce interleukin-6 gene expression and release. Evidence for a cytoprotective autocrine signaling pathway in a cardiac myocyte model system.
    Craig R; Larkin A; Mingo AM; Thuerauf DJ; Andrews C; McDonough PM; Glembotski CC
    J Biol Chem; 2000 Aug; 275(31):23814-24. PubMed ID: 10781614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular endothelial growth factor effects on nuclear factor-kappaB activation in hematopoietic progenitor cells.
    Dikov MM; Oyama T; Cheng P; Takahashi T; Takahashi K; Sepetavec T; Edwards B; Adachi Y; Nadaf S; Daniel T; Gabrilovich DI; Carbone DP
    Cancer Res; 2001 Mar; 61(5):2015-21. PubMed ID: 11280761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-kappa B by targeting the I kappa B kinase complex.
    Hehner SP; Hofmann TG; Dröge W; Schmitz ML
    J Immunol; 1999 Nov; 163(10):5617-23. PubMed ID: 10553091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bcl-2 intersects the NFkappaB signalling pathway and suppresses apoptosis in ventricular myocytes.
    Kirshenbaum LA
    Clin Invest Med; 2000 Oct; 23(5):322-30. PubMed ID: 11055326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disruption of NF-kappa B signaling and chemokine gene activation by retroviral mediated expression of IKK gamma/NEMO mutants.
    Le Page C; Popescu O; Génin P; Lian J; Paquin A; Galipeau J; Hiscott J
    Virology; 2001 Aug; 286(2):422-33. PubMed ID: 11485410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of IKK beta as therapeutic target in airway inflammatory disease by adenoviral-mediated delivery of dominant-negative IKK beta to pulmonary epithelial cells.
    Catley MC; Chivers JE; Holden NS; Barnes PJ; Newton R
    Br J Pharmacol; 2005 May; 145(1):114-22. PubMed ID: 15723090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.